ATI PHYSICAL THERAPY INC (ATIP) Fundamental Analysis & Valuation
NYSE:ATIP • US00216W2089
Current stock price
1.79 USD
+0.11 (+6.55%)
At close:
1.78 USD
-0.01 (-0.56%)
After Hours:
This ATIP fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ATIP Profitability Analysis
1.1 Basic Checks
- In the past year ATIP has reported negative net income.
- In the past year ATIP has reported a negative cash flow from operations.
1.2 Ratios
- ATIP has a worse Return On Assets (-8.23%) than 66.97% of its industry peers.
- Looking at the Return On Equity, with a value of -109.28%, ATIP is doing worse than 78.90% of the companies in the same industry.
- ATIP's Return On Invested Capital of 0.61% is in line compared to the rest of the industry. ATIP outperforms 40.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.23% | ||
| ROE | -109.28% | ||
| ROIC | 0.61% |
ROA(3y)-36.2%
ROA(5y)N/A
ROE(3y)-177.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Operating Margin of ATIP (0.86%) is comparable to the rest of the industry.
- ATIP's Gross Margin of 16.13% is on the low side compared to the rest of the industry. ATIP is outperformed by 67.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 16.13% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ATIP Health Analysis
2.1 Basic Checks
- ATIP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, ATIP has more shares outstanding
- The debt/assets ratio for ATIP is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -1.30, we must say that ATIP is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ATIP (-1.30) is worse than 82.57% of its industry peers.
- A Debt/Equity ratio of 7.55 is on the high side and indicates that ATIP has dependencies on debt financing.
- The Debt to Equity ratio of ATIP (7.55) is worse than 84.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.55 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.3 |
ROIC/WACC0.08
WACC8.12%
2.3 Liquidity
- ATIP has a Current Ratio of 1.12. This is a normal value and indicates that ATIP is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.12, ATIP is not doing good in the industry: 70.64% of the companies in the same industry are doing better.
- ATIP has a Quick Ratio of 1.12. This is a normal value and indicates that ATIP is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.12, ATIP is not doing good in the industry: 64.22% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 |
3. ATIP Growth Analysis
3.1 Past
- ATIP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.86%, which is quite impressive.
- The Revenue has grown by 9.35% in the past year. This is quite good.
EPS 1Y (TTM)65.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.99%
Revenue 1Y (TTM)9.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.06%
3.2 Future
- Based on estimates for the next years, ATIP will show a very strong growth in Earnings Per Share. The EPS will grow by 29.99% on average per year.
- Based on estimates for the next years, ATIP will show a small growth in Revenue. The Revenue will grow by 6.81% on average per year.
EPS Next Y59.22%
EPS Next 2Y29.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.11%
Revenue Next 2Y6.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. ATIP Valuation Analysis
4.1 Price/Earnings Ratio
- ATIP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year ATIP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ATIP is valued a bit cheaper than 62.39% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 12.9 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as ATIP's earnings are expected to grow with 29.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.99%
EPS Next 3YN/A
5. ATIP Dividend Analysis
5.1 Amount
- ATIP does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ATIP Fundamentals: All Metrics, Ratios and Statistics
1.79
+0.11 (+6.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)N/A N/A
Inst Owners68.21%
Inst Owner Change-99.99%
Ins Owners66.19%
Ins Owner Change0%
Market Cap7.89M
Revenue(TTM)741.86M
Net Income(TTM)-79.62M
Analysts45.71
Price Target3.06 (70.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-94.58%
Min EPS beat(2)-198.57%
Max EPS beat(2)9.42%
EPS beat(4)2
Avg EPS beat(4)-37.24%
Min EPS beat(4)-198.57%
Max EPS beat(4)43.64%
EPS beat(8)3
Avg EPS beat(8)-144.22%
EPS beat(12)6
Avg EPS beat(12)-88.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-2.81%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-2.81%
Max Revenue beat(4)0.75%
Revenue beat(8)4
Avg Revenue beat(8)-0.33%
Revenue beat(12)4
Avg Revenue beat(12)-1.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-45.45%
PT rev (3m)-45.45%
EPS NQ rev (1m)-19.47%
EPS NQ rev (3m)4.21%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.96%
Revenue NQ rev (3m)-3.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.11 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.9 |
EPS(TTM)-18.57
EYN/A
EPS(NY)-9.63
Fwd EYN/A
FCF(TTM)-8.62
FCFYN/A
OCF(TTM)-5.89
OCFYN/A
SpS168.22
BVpS16.52
TBVpS-104.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.23% | ||
| ROE | -109.28% | ||
| ROCE | 0.78% | ||
| ROIC | 0.61% | ||
| ROICexc | 0.63% | ||
| ROICexgc | 1.91% | ||
| OM | 0.86% | ||
| PM (TTM) | N/A | ||
| GM | 16.13% | ||
| FCFM | N/A |
ROA(3y)-36.2%
ROA(5y)N/A
ROE(3y)-177.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.55 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 13.27 | ||
| Cap/Depr | 34.35% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.11 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | -1.3 |
F-Score5
WACC8.12%
ROIC/WACC0.08
Cap/Depr(3y)75.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.53%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-156.99%
EPS Next Y59.22%
EPS Next 2Y29.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.35%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.06%
Revenue Next Year9.11%
Revenue Next 2Y6.81%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y119.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year234.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.43%
OCF growth 3YN/A
OCF growth 5YN/A
ATI PHYSICAL THERAPY INC / ATIP Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ATI PHYSICAL THERAPY INC (ATIP) stock?
ChartMill assigns a fundamental rating of 1 / 10 to ATIP.
What is the valuation status for ATIP stock?
ChartMill assigns a valuation rating of 1 / 10 to ATI PHYSICAL THERAPY INC (ATIP). This can be considered as Overvalued.
What is the profitability of ATIP stock?
ATI PHYSICAL THERAPY INC (ATIP) has a profitability rating of 1 / 10.
Can you provide the financial health for ATIP stock?
The financial health rating of ATI PHYSICAL THERAPY INC (ATIP) is 1 / 10.